Author Index

Search or browse for an author across our entire electronic archive

Search results for: L
Results 1 - 10 of 1597 shown below

  • Lægreid, A

    E Hofsli, T E Wheeler, M Langaas, A Lægreid and L Thommesen

    Identification of novel neuroendocrine-specific tumour genes

    advance online publication, 2008-09-30 00:00:00.000;

    doi:10.1038/sj.bjc.6604565

    Abstract | Full article | PDF

  • Lænkholm, A-V

    S Hansen, J Overgaard, C Rose, Ann Knoop, A-V Lænkholm, J Andersen, F B Sørensen and P A Andreasen

    Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

    doi:10.1038/sj.bjc.6600662

    Abstract | Full article | PDF

  • Läärä, E

    J T Korpi, V Kervinen, H Mäklin, A Väänänen, M Lahtinen, E Läärä, A Ristimäki, G Thomas, M Ylipalosaari, P Åström, C Lopez-Otin, T Sorsa, S Kantola, E Pirilä and T Salo

    Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer

    advance online publication, 2008-02-05 00:00:00.000;

    doi:10.1038/sj.bjc.6604239

    Abstract | Full article | PDF

  • Léger, F

    F Léger, W J Loos, J Fourcade, R Bugat, M Goffinet, R H J Mathijssen, J Verweij, A Sparreboom and E Chatelut

    Factors affecting pharmacokinetic variability of oral topotecan: a population analysis

    doi:10.1038/sj.bjc.6601469

    Abstract | Full article | PDF

  • Léoné, M

    O M Sinilnikova, A C Antoniou, J Simard, S Healey, M Léoné, D Sinnett, A B Spurdle, J Beesley, X Chen, M H Greene, J T Loud, F Lejbkowicz, G Rennert, S Dishon, I L Andrulis, S M Domchek, K L Nathanson, S Manoukian, P Radice, I Konstantopoulou, I Blanco, A L Laborde, M Durán, A Osorio, J Benitez, U Hamann, F B L Hogervorst, T A M van Os, H J P Gille, S Peock, M Cook, C Luccarini, D G Evans, F Lalloo, R Eeles, G Pichert, R Davidson, T Cole, J Cook, J Paterson, C Brewer, D J Hughes, I Coupier, S Giraud, F Coulet, C Colas, F Soubrier, E Rouleau, I Bièche, R Lidereau, L Demange, C Nogues, H T Lynch, R K Schmutzler, B Versmold, C Engel, A Meindl, N Arnold, C Sutter, H Deissler, D Schaefer, U G Froster, K Aittomäki, H Nevanlinna, L McGuffog, D F Easton, G Chenevix-Trench and D Stoppa-Lyonnet

    The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

    advance online publication, 2009-08-25 00:00:00.000;

    doi:10.1038/sj.bjc.6605279

    Abstract | Full article | PDF

  • Léon-Goddard, S

    G Grelier, N Voirin, A-S Ay, D G Cox, S Chabaud, I Treilleux, S Léon-Goddard, R Rimokh, I Mikaelian, C Venoux, A Puisieux, C Lasset and C Moyret-Lalle

    Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype

    doi:10.1038/sj.bjc.6605193

    Abstract | Full article | PDF

  • Lépicier, P

    M C Filion, P Lépicier, A Morales and N C Phillips

    Mycobacterium phlei cell wall complex directly induces apoptosis in human bladder cancer cells

    doi:10.1038/sj.bjc.6690038

    Abstract | Full article | PDF

  • Lévi, F

    T G Granda, R-M D'Attino, E Filipski, P Vrignaud, C Garufi, E Terzoli, M-C Bissery and F Lévi

    Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma

    doi:10.1038/sj.bjc.6600168

    Abstract | Full article | PDF

  • X M Li, K Tanaka, J Sun, E Filipski, L Kayitalire, C Focan and F Lévi

    Preclinical relevance of dosing time for the therapeutic index of gemcitabine–cisplatin

    advance online publication, 2005-04-19 00:00:00.000;

    doi:10.1038/sj.bjc.6602564

    Abstract | Full article | PDF

  • M A Bensmaïne, M Marty, A de Gramont, S Brienza, F Lévi, M Ducreux, E François, E Gamelin, H Bleiberg and E Cvitkovic

    Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) plusminus folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients

    doi:10.1054/bjoc.2001.1953

    Abstract | Full article | PDF

  • Lévy, C

    N Soufir, B Bressac-de Paillerets, L Desjardins, C Lévy, J Bombled, I Gorin, P Schlienger and D Stoppa-Lyonnet

    Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes

    doi:10.1054/bjoc.1999.1005

    Abstract | Full article | PDF

  • Lévy, E

    I Ray-Coquard, B Weber, J Cretin, Z Haddad-Guichard, E Lévy, A C Hardy-Bessard, M C Gouttebel, J-F Geay, A Aleba, H Orfeuvre, C Agostini, J Provencal, J M Ferrero, D Fric, N Dohollou, D Paraiso, J Salvat and É Pujade-Lauraine

    Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group

    advance online publication, 2009-02-03 00:00:00.000;

    doi:10.1038/sj.bjc.6604878

    Abstract | Full article | PDF